Analyst Consensus
- Current Price
- 310.58 $
- Target (Low)
- 110.00 $
- Target (Mean)
- 238.75 $
- Target (High)
- 385.00 $
- Recommendation
- Strong Buy
- Number of Analysts
- 41
Recommendation Distribution
Recommendation Distribution| Strong Buy | 7 |
|---|
| Buy | 31 |
|---|
| Hold | 5 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 1 |
|---|
Key Ratios
- Net Profit Margin
- 29.0%
- Operating Margin
- 14.5%
- Gross Margin
- 51.5%
- Return on Equity (ROE)
- 16.0%
- Return on Assets (ROA)
- 3.8%
- Revenue Growth
- 27.6%
- Earnings Growth
- -80.4%
- Debt/Equity
- 28.97
- Current Ratio
- 3.28
- Beta
- 2.28
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 18, 2026 | Keybanc | Overweight → Overweight |
| Jun 12, 2026 | Rosenblatt | Buy → Buy |
| Jun 12, 2026 | B. Riley Securities | Buy → Buy |
| May 29, 2026 | Barclays | Overweight → Overweight |
| May 28, 2026 | UBS | Buy → Buy |
| May 28, 2026 | Citigroup | Buy → Buy |